| Christopher Donovan, MD | |
|
403 Vonderburg Dr, Brandon, FL 33511-5982 | |
| (813) 681-1122 | |
| (813) 684-4924 |
| Full Name | Christopher Donovan |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 8 Years |
| Location | 403 Vonderburg Dr, Brandon, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770945982 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME145746 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gregory L Henderson Md Facs Inc | 9739172321 | 30 |
News Archive
A decade of refinements in marrow and stem cell transplantation to treat blood cancers significantly reduced the risk of treatment-related complications and death, according to an institutional self-analysis of transplant-patient outcomes conducted at Fred Hutchinson Cancer Research Center.
The Congressional Budget Office projects that rebounding revenue, combined with the force of the debt-reduction deal that became law earlier this month, will reduce the deficit by an estimated $3.3 trillion.
At the beginning of September, Mellow Hope completed the clinical trial of Influenza A (H1N1) Vaccine (Split Virion). The company received the clinical approval from the State Food and Drug Administration (SFDA) http://eng.sfda.gov.cn/eng. Production will be started shortly.
The University of Maryland Biotechnology Institute (UMBI) today announced the exclusive licensing of a fully human antibody technology platform to Prolias, a biotechnology company working to discover and develop novel therapeutic proteins and antibodies for treatment of disease.
› Verified 6 days ago
| Entity Name | University Medical Service Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992742324 PECOS PAC ID: 6800790221 Enrollment ID: O20031126000130 |
News Archive
A decade of refinements in marrow and stem cell transplantation to treat blood cancers significantly reduced the risk of treatment-related complications and death, according to an institutional self-analysis of transplant-patient outcomes conducted at Fred Hutchinson Cancer Research Center.
The Congressional Budget Office projects that rebounding revenue, combined with the force of the debt-reduction deal that became law earlier this month, will reduce the deficit by an estimated $3.3 trillion.
At the beginning of September, Mellow Hope completed the clinical trial of Influenza A (H1N1) Vaccine (Split Virion). The company received the clinical approval from the State Food and Drug Administration (SFDA) http://eng.sfda.gov.cn/eng. Production will be started shortly.
The University of Maryland Biotechnology Institute (UMBI) today announced the exclusive licensing of a fully human antibody technology platform to Prolias, a biotechnology company working to discover and develop novel therapeutic proteins and antibodies for treatment of disease.
› Verified 6 days ago
| Entity Name | Gregory L Henderson Md Facs Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306839725 PECOS PAC ID: 9739172321 Enrollment ID: O20040722001097 |
News Archive
A decade of refinements in marrow and stem cell transplantation to treat blood cancers significantly reduced the risk of treatment-related complications and death, according to an institutional self-analysis of transplant-patient outcomes conducted at Fred Hutchinson Cancer Research Center.
The Congressional Budget Office projects that rebounding revenue, combined with the force of the debt-reduction deal that became law earlier this month, will reduce the deficit by an estimated $3.3 trillion.
At the beginning of September, Mellow Hope completed the clinical trial of Influenza A (H1N1) Vaccine (Split Virion). The company received the clinical approval from the State Food and Drug Administration (SFDA) http://eng.sfda.gov.cn/eng. Production will be started shortly.
The University of Maryland Biotechnology Institute (UMBI) today announced the exclusive licensing of a fully human antibody technology platform to Prolias, a biotechnology company working to discover and develop novel therapeutic proteins and antibodies for treatment of disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Donovan, MD 403 Vonderburg Dr, Brandon, FL 33511-5982 Ph: (813) 681-1122 | Christopher Donovan, MD 403 Vonderburg Dr, Brandon, FL 33511-5982 Ph: (813) 681-1122 |
News Archive
A decade of refinements in marrow and stem cell transplantation to treat blood cancers significantly reduced the risk of treatment-related complications and death, according to an institutional self-analysis of transplant-patient outcomes conducted at Fred Hutchinson Cancer Research Center.
The Congressional Budget Office projects that rebounding revenue, combined with the force of the debt-reduction deal that became law earlier this month, will reduce the deficit by an estimated $3.3 trillion.
At the beginning of September, Mellow Hope completed the clinical trial of Influenza A (H1N1) Vaccine (Split Virion). The company received the clinical approval from the State Food and Drug Administration (SFDA) http://eng.sfda.gov.cn/eng. Production will be started shortly.
The University of Maryland Biotechnology Institute (UMBI) today announced the exclusive licensing of a fully human antibody technology platform to Prolias, a biotechnology company working to discover and develop novel therapeutic proteins and antibodies for treatment of disease.
› Verified 6 days ago
David S Nichols, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 403 Vonderburg Dr, Ste 101, Brandon, FL 33511 Phone: 813-681-1122 Fax: 813-684-4924 | |
William A Reeves, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 403 Vonderburg Dr, Brandon, FL 33511 Phone: 813-681-1122 Fax: 813-684-4924 | |
Dr. Michael Anthony Lopez, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 403 Vonderburg Dr, Brandon, FL 33511 Phone: 813-681-1122 Fax: 813-684-4924 | |
Dr. Ronni M Chen, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 403 Vonderburg Dr, 101, Brandon, FL 33511 Phone: 813-681-1122 Fax: 813-684-4924 | |
Jose Perez Gonzalez De Apodaca, M.D./PH.D Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 206 Buckingham Pl Ste 102, Brandon, FL 33511 Phone: 813-653-2020 Fax: 813-653-2205 | |
Mr. Byron Edward Holley, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1011 Cherwood Ln, Brandon, FL 33511 Phone: 813-681-1456 Fax: 813-684-6451 | |
Dr. Jennifer Sara Landy, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 540 Medical Oaks Ave Ste 103, Brandon, FL 33511 Phone: 813-684-2211 Fax: 813-685-0895 |